- Study of ovarian cancer CTCs using Parsortix
- New commercial agreement with large pharma
- New commercial agreement with AstraZeneca
- US and EU patents for innovative CellKeepâ„¢ slide
- Parsortix HER2 assay showcased at AACR 2024
- Parsortix at European breast cancer conference
- Potential utility in precision oncology
- Standard form for notification of major holdings
- Breakthrough clinical results
- Contract announcement with Eisai Inc.
More ▼
Key statistics
On Wednesday, Angle PLC (AGL:LSE) closed at 19.25, 112.32% above the 52 week low of 9.07 set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 20.50 |
---|---|
High | 21.00 |
Low | 21.00 |
Bid | 18.00 |
Offer | 21.00 |
Previous close | 19.25 |
Average volume | 2.27m |
---|---|
Shares outstanding | 260.58m |
Free float | 232.60m |
P/E (TTM) | -- |
Market cap | 53.42m GBP |
EPS (TTM) | -0.086 GBP |
Data delayed at least 20 minutes, as of May 22 2024 17:09 BST.
More ▼